Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;23(2):267-275.
doi: 10.1002/wps.21203.

Absolute and relative outcomes of psychotherapies for eight mental disorders: a systematic review and meta-analysis

Affiliations

Absolute and relative outcomes of psychotherapies for eight mental disorders: a systematic review and meta-analysis

Pim Cuijpers et al. World Psychiatry. 2024 Jun.

Abstract

Psychotherapies are first-line treatments for most mental disorders, but their absolute outcomes (i.e., response and remission rates) are not well studied, despite the relevance of such information for health care users, providers and policy makers. We aimed to examine absolute and relative outcomes of psychotherapies across eight mental disorders: major depressive disorder (MDD), social anxiety disorder, panic disorder, generalized anxiety disorder (GAD), specific phobia, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and borderline personality disorder (BPD). We used a series of living systematic reviews included in the Metapsy initiative (www.metapsy.org), with a common strategy for literature search, inclusion of studies and extraction of data, and a common format for the analyses. Literature search was conducted in major bibliographical databases (PubMed, PsycINFO, Embase, and the Cochrane Register of Controlled Trials) up to January 1, 2023. We included randomized controlled trials comparing psychotherapies for any of the eight mental disorders, established by a diagnostic interview, with a control group (waitlist, care-as-usual, or pill placebo). We conducted random-effects model pairwise meta-analyses. The main outcome was the absolute rate of response (at least 50% symptom reduction between baseline and post-test) in the treatment and control conditions. Secondary outcomes included the relative risk (RR) of response, and the number needed to treat (NNT). Random-effects meta-analyses of the included 441 trials (33,881 patients) indicated modest response rates for psychotherapies: 0.42 (95% CI: 0.39-0.45) for MDD; 0.38 (95% CI: 0.33-0.43) for PTSD; 0.38 (95% CI: 0.30-0.47) for OCD; 0.38 (95% CI: 0.33-0.43) for panic disorder; 0.36 (95% CI: 0.30-0.42) for GAD; 0.32 (95% CI: 0.29-0.37) for social anxiety disorder; 0.32 (95% CI: 0.23-0.42) for specific phobia; and 0.24 (95% CI: 0.15-0.36) for BPD. Most sensitivity analyses broadly supported these findings. The RRs were significant for all disorders, except BPD. Our conclusion is that most psychotherapies for the eight mental disorders are effective compared with control conditions, but absolute response rates are modest. More effective treatments and interventions for those not responding to a first-line treatment are needed.

Keywords: Psychotherapies; borderline personality disorder; depression; generalized anxiety disorder; obsessive‐compulsive disorder; panic disorder; post‐traumatic stress disorder; response rates; social anxiety disorder; specific phobia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Response rates and relative risks for response to psychotherapies (with 95% CIs in brackets). MDD – major depressive disorder, SAD – social anxiety disorder, PAN – panic disorder, GAD – generalized anxiety disorder, PHOB – specific phobia, PTSD – post‐traumatic stress disorder, OCD – obsessive‐compulsive disorder, BPD – borderline personality disorder. Grey boxes indicate control conditions and black boxes indicate psychotherapies.

References

    1. World Health Organization . World mental health report: transforming mental health for all. Geneva: World Health Organization, 2022.
    1. Leichsenring F, Steinert C, Rabung S et al. The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses. World Psychiatry 2022;21:133‐45. - PMC - PubMed
    1. Cummings P. Arguments for and against standardized mean differences (effect sizes). Arch Pediatr Adolesc Med 2011;165:592‐6. - PubMed
    1. Hieronymus F, Jauhar S, Østergaard SD. One (effect) size does not fit at all: interpreting clinical significance and effect sizes in depression treatment trials. J Psychopharmacol 2020;34:1074‐8. - PMC - PubMed
    1. Cuijpers P, Karyotaki E, Ciharova M et al. The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: a meta‐analysis. Acta Psychiatr Scand 2021;144:288‐99. - PMC - PubMed